Anti-fatigue Effect of Korean Red Ginseng in Patients With Non-alcoholic Hepatitis
- Conditions
- Fatigue
- Interventions
- Drug: KRG (Korea Red ginseng)Drug: Placebo (for KRG)
- Registration Number
- NCT02331589
- Lead Sponsor
- Chuncheon Sacred Heart Hospital
- Brief Summary
Background: Korea red ginseng (KRG) has anti-carcinogenic activity, anti-oxidant activity, and cancer related anti-fatigue.
Methods: Seventy five patients with non-alcoholic hepatitis were prospectively randomized to receive 3 weeks of KRG or placebo. Liver function test, pro-inflammatory cytokines, adiponectin, fatigue severity scale, and antioxidant activity were check and compared.
- Detailed Description
Fatigue Severity Scale
We used to be KRUPP's fatigue severity scale. The survey has nine questions as following: (1) my motivation is lower, when I am fatigued (2) exercise brings on my fatigue (3) I am easily fatigued (4) fatigue interferes with my physical functioning (5) fatigue causes frequent problems for me (6) my fatigue prevents sustained physical functioning (7) fatigue interferes with carrying out certain duties and responsibilities (8) fatigue is among my 3 most disabling symptoms (9) fatigue interferes with my work, family, or social life. All subjects scored each question on a 7-point scale (1 = strongly disagree to 4 = neither disagree nor agree to 7 = strongly agree). All fatigue severity scale calculated and collected by one research nurse (C.W.K) in the Department of Internal Medicine.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 75
- aspartate aminotransferase (AST) ≥ 50 U/L or alanine aminotransferase (ALT) ≥ 50 U/L, and Fatty liver or Hepatitis
- viral hepatitis, alcoholic hepatitis, autoimmune hepatitis, pancreatitis, hemochromatosis, Wilson's disease, drug induced liver injury, or cancer
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Korea Red Ginseng (KRG) KRG (Korea Red ginseng) KRG capsule (3,000 mg/day) for 3 weeks Placebo (for KRG) Placebo (for KRG) placebo (for KRG) for 3 weeks
- Primary Outcome Measures
Name Time Method Liver Enzymes 3 weeks of KRG aspartate aminotransferase, alanine aminotransferase, gamma glutamyl transferase, lactate dehydrogenase
- Secondary Outcome Measures
Name Time Method Pro-inflammatory Cytokine 3 weeks of KRG tumor necrosis factor-alpha, interleukin-6
Fatigue as Measured by KRUPP's Fatigue Severity Scale 3 weeks of KRG KRUPP's fatigue severity scale.
The survey has nine questions as following:
1. my motivation is lower, when I am fatigued
2. exercise brings on my fatigue
3. I am easily fatigued
4. fatigue interferes with my physical functioning
5. fatigue causes frequent problems for me
6. my fatigue prevents sustained physical functioning
7. fatigue interferes with carrying out certain duties and responsibilities
8. fatigue is among my 3 most disabling symptoms
9. fatigue interferes with my work, family, or social life. All subjects scored each question on a 7-point scale (1 = strongly disagree to 4 = neither disagree nor agree to 7 = strongly agree).
Scores range from 9 to 63, with higher scores indicating higher fatigueAdiponectin 3 weeks of KRG enzyme-linked immunosorbent assay